1H-Pyrazolo[4,3-c]pyridine-7-carboxamide, 5-[(3,4-dichlorophenyl)methyl]-4,5-dihydro-4-oxo-1-(4-piperidinyl)-N-4-pyridinyl- manufacturers
- BDP-13176
-
- $88.00
-
2026-07-14
- CAS:2290660-61-4
- Purity: 99.50%
- Supply Ability: 10g
|
| | 1H-Pyrazolo[4,3-c]pyridine-7-carboxamide, 5-[(3,4-dichlorophenyl)methyl]-4,5-dihydro-4-oxo-1-(4-piperidinyl)-N-4-pyridinyl- Basic information |
| Product Name: | 1H-Pyrazolo[4,3-c]pyridine-7-carboxamide, 5-[(3,4-dichlorophenyl)methyl]-4,5-dihydro-4-oxo-1-(4-piperidinyl)-N-4-pyridinyl- | | Synonyms: | 1H-Pyrazolo[4,3-c]pyridine-7-carboxamide, 5-[(3,4-dichlorophenyl)methyl]-4,5-dihydro-4-oxo-1-(4-piperidinyl)-N-4-pyridinyl-;BDP-13176;inhibit,BDP13176,BDP-13176,Inhibitor,BDP 13176;5-[(3,4-dichlorophenyl)methyl]-4-oxo-1-(piperidin-4-yl)-N-(pyridin-4-yl)-1H,4H,5H-pyrazolo[4,3-c]pyridine-7-carboxamide;BDP-13176, 10 mM in DMSO | | CAS: | 2290660-61-4 | | MF: | C24H22Cl2N6O2 | | MW: | 497.38 | | EINECS: | | | Product Categories: | | | Mol File: | 2290660-61-4.mol | ![1H-Pyrazolo[4,3-c]pyridine-7-carboxamide, 5-[(3,4-dichlorophenyl)methyl]-4,5-dihydro-4-oxo-1-(4-piperidinyl)-N-4-pyridinyl- Structure](CAS/20200611/GIF/2290660-61-4.gif) |
| | 1H-Pyrazolo[4,3-c]pyridine-7-carboxamide, 5-[(3,4-dichlorophenyl)methyl]-4,5-dihydro-4-oxo-1-(4-piperidinyl)-N-4-pyridinyl- Chemical Properties |
| Boiling point | 779.9±60.0 °C(Predicted) | | density | 1.50±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO: 125 mg/mL (251.32 mM) | | pka | 10.68±0.20(Predicted) | | form | Solid | | color | White to off-white |
| | 1H-Pyrazolo[4,3-c]pyridine-7-carboxamide, 5-[(3,4-dichlorophenyl)methyl]-4,5-dihydro-4-oxo-1-(4-piperidinyl)-N-4-pyridinyl- Usage And Synthesis |
| Uses | BDP-13176 is a potent fascin 1 inhibitor, with a Kd of 90 nM and an IC50 of 240 nM. BDP-13176 has potential as an anti-metastatic agent[1]. | | References | [1] Francis S, et al. Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents. Bioorg Med Chem Lett. 2019;29(8):1023-1029. DOI:10.1016/j.bmcl.2019.01.035 |
| | 1H-Pyrazolo[4,3-c]pyridine-7-carboxamide, 5-[(3,4-dichlorophenyl)methyl]-4,5-dihydro-4-oxo-1-(4-piperidinyl)-N-4-pyridinyl- Preparation Products And Raw materials |
|